Half Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded Transcript

Aug 06, 2021 / 07:00AM GMT
Presentation - Pre-Recorded
Aug 06, 2021 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

=====================
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director

Hello, everyone. I'm Siggi Olafsson, CEO of Hikma Pharmaceuticals, and I'm here with Khalid Nabilsi, our CFO. Thank you for joining our 2021 interim results presentation. I will be providing an update on our strategic progress, and then I'll hand it over to Khalid to run through the financials.

Our strategy continues to deliver, and I'm very pleased to announce a strong set of results for the first half of 2021. The breadth and resilience of our portfolio as well as our commercial and operational strength has enabled us to successfully navigate through the shifts in customers' demand as the COVID-19 pandemic has progressed.

Group core revenue was $1.2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot